0001808761-20-000001.txt : 20200409 0001808761-20-000001.hdr.sgml : 20200409 20200409084219 ACCESSION NUMBER: 0001808761-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200409 DATE AS OF CHANGE: 20200409 EFFECTIVENESS DATE: 20200409 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Black Swan Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001808761 IRS NUMBER: 832505872 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-364628 FILM NUMBER: 20783224 BUSINESS ADDRESS: STREET 1: 9008 LAURA LAKE DRIVE CITY: WAKE FOREST STATE: NC ZIP: 27587 BUSINESS PHONE: 919-612-4363 MAIL ADDRESS: STREET 1: 9008 LAURA LAKE DRIVE CITY: WAKE FOREST STATE: NC ZIP: 27587 D 1 primary_doc.xml X0708 D LIVE 0001808761 Black Swan Pharmaceuticals, Inc. 9008 LAURA LAKE DRIVE WAKE FOREST NC NORTH CAROLINA 27587 919-612-4363 DELAWARE None None Corporation true 2018 Craig Metz c/o Black Swan Pharmaceuticals, Inc. 9008 Laura Lake Drive Wake Forest NC NORTH CAROLINA 27587 Executive Officer Director Julian Arbuckle c/o Black Swan Pharmaceuticals, Inc. 9008 Laura Lake Drive Wake Forest NC NORTH CAROLINA 27587 Director Om Dhingra c/o Black Swan Pharmaceuticals, Inc. 9008 Laura Lake Drive Wake Forest NC NORTH CAROLINA 27587 Director Anthony Akkari c/o Black Swan Pharmaceuticals, Inc. 9008 Laura Lake Drive Wake Forest NC NORTH CAROLINA 27587 Director Steve Arnott c/o Black Swan Pharmaceuticals, Inc. 9008 Laura Lake Drive Wake Forest NC NORTH CAROLINA 27587 Director Pharmaceuticals Decline to Disclose 06b false 2020-03-25 false true false 0 600000 130240 469760 false 1 0 0 0 Other than the payment of salaries and other compensation and benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering. false Black Swan Pharmaceuticals, Inc. /s/ Craig Metz Craig Metz Chief Executive Officer 2020-04-09